Cover Image
市場調查報告書

生物資訊學的全球市場(使用部門、製品&服務、用途、區域別) - 市場規模、市佔率、全球動向、分析、調查、報告、機會、市場區塊以及預測

Global Bioinformatics Market (Sectors, Product & Services, Applications, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

出版商 Allied Market Research 商品編碼 305983
出版日期 內容資訊 英文 151 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物資訊學的全球市場(使用部門、製品&服務、用途、區域別) - 市場規模、市佔率、全球動向、分析、調查、報告、機會、市場區塊以及預測 Global Bioinformatics Market (Sectors, Product & Services, Applications, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
出版日期: 2014年05月14日 內容資訊: 英文 151 Pages
簡介

生物資訊學發揮在生命情報的分析、組織化、搜尋的威力,做為資料發展與保存的學科領域而活用在生物學的所有領域,其市場規模預估今後數年將維持在21.2%的年複合成長率,並在2020年達到128億6000萬美元。

本報告關注生物資訊學的全球市場,以使用部門、製品&服務、用途、區域別分析預測今後變化,並彙集發展的促進、限制因素、機會、技術研究、用途開發、競爭環境、主要參與企業等的最新情報。

第1章 簡介

  • 報告內容
  • 主要市場區塊
  • 主要優點
  • 調查方法
    • 二次情報調查
    • 主要情報取材
    • 分析工具及模式

第2章 報告摘要

第3章 生物資訊學市場概要

  • 市場的定義與範圍
  • 簡介
    • 構成要素
    • 生物學資料庫
    • 生物資訊學的使用方法
  • 產業面臨的趨勢與課題
  • 生物資訊學 - 雲端服務
  • 次世代定序服務
  • 價值鏈分析 - 生物資訊學與藥劑開發
  • 藥劑開發過程的生物資訊學
  • 專利分析
  • 重要發現
    • 影響生物資訊學市場的10大因子
    • 生物資訊學市場的重要成功策略
    • 生物資訊學市場的有力投資口袋
      • 主要投資市場 - 用途別
      • 主要投資市場 - 使用部門別
  • Poter的五力分析
  • 事例研究:超級計算集群
  • 法規
  • 市場動態
    • 促進因素
      • 對整合資料的需求
      • 蛋白質體學和基因體學的成長率提升
      • 藥物設計、藥劑開發
      • 政府獎勵措施
    • 限制因素
      • 熟練人員的必要性
      • 共通資料格式
      • 醫藥品部門的飽和
    • 機會
      • 規格化
      • 對整合解決方案和系統的需求
      • 數據超載

第4章 生物資訊學的全球市場 - 技術、服務別

  • 以技術、平台、服務別來看生物資訊學的全球市場
  • 生物資訊學的內容與知識管理工具
  • 生物資訊學平台
  • 生物資訊學服務

第5章 生物資訊學的全球市場 - 用途別

  • 生物資訊學用途的全球市場
  • 基因體學
  • 化學資訊學與藥劑設計
  • 蛋白質體學
  • 轉錄體學
  • 代謝學
  • 分子系統進化學
  • 其他用途市場
    • 藥理基因體學
    • 藥理蛋白質體學
    • 生物資訊學的其他用途市場 - 區域別

第6章 生物資訊學的全球市場 - 使用部門別

  • 以使用部門別來看生物資訊學市場
  • 醫療生物資訊學
    • 藥劑開發
    • 分子醫學
    • 預防醫學
    • 基因治療
    • 醫療生物資訊學 - 區域別
  • 動物生物資訊學
  • 農業生物資訊學
  • 學術研究
  • 其他(微生物基因體)

第7章 生物資訊學的全球市場 - 區域別

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 企業檔案資料(企業概要、速覽、業績、策略動向及發展、SWOT分析)

  • Accelrys, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Geneva Bioinformatics (Genebio) SA
  • Nonlinear Dynamics
  • Quest Diagnostics, Inc.
  • Illumina
  • Bruker Daltonics Inc
  • Biomax Informatics AG
  • Life Technologies Corporation
目錄
Product Code: DI 14136

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc.

The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives. The factor limiting this market is the need for skilled personnel due to the complexity of the bioinformatics tools used. The other limiting factors are the saturation of the pharmaceutical sectors and lack of common data formats. The factors that would provide opportunity for the growth of this market are standardization of databases, need for integration systems and solutions and need to control data overload due to the piling-up of data due to the numerous experiments conducted. The reason to study this market is to understand the current trends and applications in the bioinformatics field along with in depth analysis of the segments.

Bioinformatics Technology and Services Market Analysis

The bioinformatics technology and services market is segmented into knowledge management tools, bioinformatics platforms and bioinformatics services. The Bioinformatics platform market was the highest revenue generating market in 2013. This was due to the increased application usage of the platforms in various genomic applications. However, the Knowledge Management Tools is expected to emerge as the highest revenue generating segment by 2020 due to the increasing number of data generated due to the increasing clinical trials.

Bioinformatics Application Market Analysis

The bioinformatics application market is segmented based on, metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics and others. The Genomics was the highest revenue generating market among the bioinformatics application market in 2013. This was due to the increased applications in drug discovery and development using bioinformatics tools. The tools proved to be cost and time efficient for the pharmaceutical companies. The Chemoinformatics and Drug Design is expected to be the highest revenue generating segment by 2020 due to its ability to use information in the selection and designing of the drug cycle.

Bioinformatics Sector Market Analysis

The bioinformatics sector is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others. The Medical bioinformatics was and is forecast to be the highest revenue generating market through 2020. This was due to the increasing application of drug discovery and development using bioinformatics tools, which were also used in the preventive medicine and gene therapy.

Bioinformatics Geographic Market Analysis

The geography segment is segmented into North America, Europe, Asia Pacific and RoW. North America was the highest revenue generating region in 2013 due to the wider adoption of advanced technology in the region. North America was followed by Europe as the second largest revenue generating segment in 2013 due to the continuous adoption of new technology in the field of drug discovery and development. The market scenario for bioinformatics is expected to remain same throughout the forecast period.

Competitive Landscape

The key companies profiled in this report are Accelrys, Inc., Affymetrix, Inc., Agilent Technologies, Inc., Geneva bioinformatics, Non linear dynamics, Quest Diagnostics, Inc., Life Technologies corp., Illumina, Bruker Daltonics, Inc., and Biomax Informatics AG. The key strategies opted by the market players are Product Launch, Agreement and Collaboration.

High Level Analysis

The market analysis is done based on Porter's five forces model and Value chain analysis. According to the Porter's five forces model the bargaining power of the supplier's is low due to the presence of many bioinformatics service providers and the threat from internal substitutes of this market is moderate. According to the value chain analysis the major revenue is generated from the drug discovery segment. In the past, the R&D activity in the biotechnology and pharmaceutical industry had a restrictive budget. However, due to the advancement in the IT solutions, the cost involved in the R&D activity has become cost and time efficient.

Key Benefits

  • The report provides detailed analysis about the driving and limiting factors of the Bioinformatics market, which would give a deeper understanding of the subject and help in analyzing the various applications of bioinformatics
  • The application market helps in analyzing the various application segments, thus helping the stakeholders understand opportunities in the various fields of bioinformatics market
  • To understand the bioinformatics market and its segments and to gain a deeper understanding of trends adopted
  • The report analyzes the market conditions in a comprehensive and quantitative manner and forecast market trends and techniques used in bioinformatics
  • The market is forecast in terms of revenue throughout 2013 to 2020.

Key Deliverables

The global Bioinformatics market is segmented based on technology & services, application, sector and geography.

BY TECHNOLOGY AND SERVICES

  • Knowledge Management Tools
  • Generalized knowledge management tools
  • Specialized knowledge management tools
  • Bioinformatics Platforms
  • Sequence analysis platforms
  • Sequence alignment platforms
  • Sequence manipulation platforms
  • Structural analysis platforms
  • Others
  • Bioinformatics Services
  • Sequencing services
  • Database and management
  • Data Analysis
  • Others

BY APPLICATION

  • Metabolomics
  • Molecular Phylogenetics
  • Transcriptomics
  • Proteomics
  • Chemoinformatics
  • Genomics
  • Others

BY SECTOR

  • Medical Bioinformatics
  • Animal Bioinformatics
  • Agriculture Bioinformatics
  • Academics
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

Table of Contents

CHAPTER 1 - INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key benefits
  • 1.4. Research methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

CHAPTER 2 - EXECUTIVE SUMMARY

CHAPTER 3 - BIOINFORMATICS MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Introduction
    • 3.2.1. Components
    • 3.2.2. Biological Databases
    • 3.2.3. Applications of bioinformatics
  • 3.3. Trends and challenges faced by the industry
  • 3.4. Bioinformatics - cloud services
  • 3.5. Next-generation sequencing services
  • 3.6. Value chain analysis - bioinformatics and drug development
  • 3.7. Bioinformatics in the drug development process
  • 3.8. Patent analysis
  • 3.9. Key findings
    • 3.9.1. Top ten factors impacting Bioinformatics market
    • 3.9.2. Top winning strategies in the Bioinformatics market
    • 3.9.3. Top investment pockets in Bioinformatics market
      • 3.9.3.1. Top investment markets by application
      • 3.9.3.2. Top investment markets by sector
  • 3.10. Porter's five-forces analysis
    • 3.10.1. Bargaining power of suppliers is low
    • 3.10.2. Bargaining power of the buyer is high
    • 3.10.3. Threats for new entrants
    • 3.10.4. High competition
    • 3.10.5. Threat from substitutes
  • 3.11. Case study: Supercomputing Cluster
  • 3.12. Regulations
  • 3.13. Market dynamics
    • 3.13.1. Drivers
      • 3.13.1.1. Need for integrated data
      • 3.13.1.2. Increasing growth in proteomics and genomics
      • 3.13.1.3. Drug discovery and development
      • 3.13.1.4. Government initiatives
    • 3.13.2. Restraints
      • 3.13.2.1. Need for skilled PERSONNEL
      • 3.13.2.2. Common data formats
      • 3.13.2.3. Pharmaceutical sector saturation
    • 3.13.3. Opportunities
      • 3.13.3.1. Standardization
      • 3.13.3.2. Need for integrated solutions and systems
      • 3.13.3.3. Data overload

CHAPTER 4 - GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY AND SERVICES

  • 4.1. Global bioinformatics market by technology, platforms and services
  • 4.2. Bioinformatics Content/Knowledge Management Tools
    • 4.2.1. Global bioinformatics knowledge management tools market by type
    • 4.2.2. Bioinformatics knowledge management tools market by geography
    • 4.2.3. Generalized knowledge management tools
      • 4.2.3.1. Bioinformatics Generalized Knowledge Management Tools market by geography
    • 4.2.4. Specialized knowledge management
      • 4.2.4.1. Bioinformatics Specialized Knowledge Management Tools market by geography
  • 4.3. Bioinformatics Platforms
    • 4.3.1. Global bioinformatics platforms market by type
    • 4.3.2. Bioinformatics platforms market by geography
    • 4.3.3. Sequence Analysis Platforms
      • 4.3.3.1. Bioinformatics Sequence Analysis platform market by geography
    • 4.3.4. Sequence alignment platforms
      • 4.3.4.1. Bioinformatics Sequence alignment platform market by geography
    • 4.3.5. Sequence Manipulation Platforms
      • 4.3.5.1. Bioinformatics Sequence Manipulation platform market by geography
    • 4.3.6. Structural Analysis Platforms
      • 4.3.6.1. Bioinformatics Structural Analysis platform market by geography
    • 4.3.7. Other Platforms
      • 4.3.7.1. Bioinformatics others platform market by geography
  • 4.4. Bioinformatics services
    • 4.4.1. Global bioinformatics service market
    • 4.4.2. Bioinformatics services market by geography
    • 4.4.3. Sequencing Services
      • 4.4.3.1. Bioinformatics Sequencing Services market by geography
    • 4.4.4. Database and Management
      • 4.4.4.1. Bioinformatics database &management Services market by geography
    • 4.4.5. Data Analysis
      • 4.4.5.1. Bioinformatics data analysis Services market by geography
    • 4.4.6. Others (Data services) market
      • 4.4.6.1. Bioinformatics other Services market by geography

CHAPTER 5 - GLOBAL BIOINFORMATICS MARKET BY APPLICATION

  • 5.1. Global bioinformatics application market
  • 5.2. Genomics
    • 5.2.1. Bioinformatics genomics application market by geography
  • 5.3. Chemoinformatics and Drug Design
    • 5.3.1. Bioinformatics chemoinformatics and drug design application market by geography
  • 5.4. Proteomics
    • 5.4.1. Bioinformatics Proteomics application market by geography
  • 5.5. Transcriptomics
    • 5.5.1. Bioinformatics Transcriptomics application market by geography
  • 5.6. Metabolomics
    • 5.6.1. Bioinformatics Metabolomics application market by geography
  • 5.7. Molecular Phylogenetics
    • 5.7.1. Bioinformatics Molecular Phylogenetics application market by geography
  • 5.8. Other application market
    • 5.8.1. Pharmacogenomics
    • 5.8.2. Pharmacoproteomics
    • 5.8.3. Bioinformatics other application market by geography

CHAPTER 6 - GLOBAL BIOINFORMATICS MARKET BY SECTOR

  • 6.1. Global Bioinformatics market by sector
  • 6.2. Medical bioinformatics
    • 6.2.1. Drug development
    • 6.2.2. Molecular medicine
    • 6.2.3. Preventive medicine
    • 6.2.4. Gene therapy
    • 6.2.5. Medical Bioinformatics sector market by geography
  • 6.3. Animal Bioinformatics
    • 6.3.1. Animal Bioinformatics sector market by geography
  • 6.4. Agricultural bioinformatics
    • 6.4.1. Crop yield improvement
    • 6.4.2. Pest resistance
    • 6.4.3. Plant resistance against abiotic stresses
    • 6.4.4. Improve nutritional quality
    • 6.4.5. Agriculture bioinformatics sector market by geography
  • 6.5. Academics
    • 6.5.1. Global Bioinformatics Academics sector market by geography
  • 6.6. Others (Microbial genome)
    • 6.6.1. Bioinformatics other sectors market by geography

CHAPTER 7 - GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHY

  • 7.1. North America
    • 7.1.1. North America bioinformatics market
  • 7.2. Europe
    • 7.2.1. Europe bioinformatics market
  • 7.3. Asia pacific
    • 7.3.1. Asia Pacific bioinformatics market
  • 7.4. RoW
    • 7.4.1. RoW bioinformatics market

CHAPTER 8 - COMPANY PROFILES

  • 8.1. Accelrys, Inc.
    • 8.1.1. Company overview
    • 8.1.2. Company snapshot
    • 8.1.3. Business performance
    • 8.1.4. Strategic moves and developments
    • 8.1.5. SWOT Analysis of Accelrys, Inc
  • 8.2. Affymetrix, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Company snapshot
    • 8.2.3. Business performance
    • 8.2.4. Strategic moves and developments
    • 8.2.5. SWOT Analysis of Affymetrix, Inc
  • 8.3. Agilent Technologies, Inc.
    • 8.3.1. Company overview
    • 8.3.2. Company snapshot
    • 8.3.3. Business performance
    • 8.3.4. Strategic moves and developments
    • 8.3.5. SWOT Analysis of Agilent technologies, Inc
  • 8.4. Geneva Bioinformatics (Genebio) SA
    • 8.4.1. Company overview
    • 8.4.2. Company snapshot
    • 8.4.3. Strategic moves and developments
    • 8.4.4. SWOT Analysis of Geneva Bioinformatics (GeneBio) SA
  • 8.5. Nonlinear Dynamics
    • 8.5.1. Company overview
    • 8.5.2. Company snapshot
    • 8.5.3. Strategic moves and developments
    • 8.5.4. SWOT Analysis of Nonlinear Dynamics Ltd.
  • 8.6. Quest Diagnostics, Inc.
    • 8.6.1. Company overview
    • 8.6.2. Company snapshot
    • 8.6.3. Business performance
    • 8.6.4. Strategic moves and developments
      • 8.6.4.1. Primary Strategies
      • 8.6.4.2. Secondary Strategies
    • 8.6.5. SWOT Analysis of Quest Diagnostics
  • 8.7. Illumina
    • 8.7.1. Company overview
    • 8.7.2. Company snapshot
    • 8.7.3. Business performance
    • 8.7.4. Strategic moves and developments
      • 8.7.4.1. Primary Strategies
      • 8.7.4.2. Secondary Strategies
    • 8.7.5. SWOT Analysis of Illumina, Inc.
  • 8.8. Bruker Daltonics Inc
    • 8.8.1. Company overview
    • 8.8.2. Company snapshot
    • 8.8.3. Business performance
    • 8.8.4. Strategic moves and developments
      • 8.8.4.1. Primary Strategies
    • 8.8.5. SWOT Analysis of Bruker Daltonics, Inc.
  • 8.9. Biomax Informatics AG
    • 8.9.1. Company overview
    • 8.9.2. Company snapshot
    • 8.9.3. Strategic moves and developments
      • 8.9.3.1. Primary Strategies
      • 8.9.3.2. Secondary Strategies
    • 8.9.4. SWOT Analysis of Biomax Informatics AG
  • 8.10. Life Technologies Corporation
    • 8.10.1. Company overview
    • 8.10.2. Company snapshot
    • 8.10.3. Business performance
    • 8.10.4. Strategic moves and developments
      • 8.10.4.1. Primary Strategies
      • 8.10.4.2. Secondary Strategies
    • 8.10.5. SWOT Analysis of Life technologies

LIST OF TABLES:

  • TABLE 1: BIOINFORMATICS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
  • TABLE 2: LIST OF PATENT
  • TABLE 3: GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY, PLATFORMS AND SERVICES, 2013-2020($MILLION)
  • TABLE 4: GLOBAL BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET BY TYPE, 2013-2020 ($MILLION)
  • TABLE 5: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 6: BIOINFORMATICS GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 7: BIOINFORMATICS SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 8: GLOBAL BIOINFORMATICS MARKET, BY PLATFORMS
  • TABLE 9: BIOINFORMATICS PLATFORMS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
  • TABLE 10: BIOINFORMATICS SEQUENCE ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 11: BIOINFORMATICS SEQUENCE ALIGNMENT PLATFORM MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 12: BIOINFORMATICS SEQUENCE MANIPULATION PLATFORM MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 13: BIOINFORMATICS STRUCTURAL ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 14: BIOINFORMATICS OTHERS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 15: GLOBAL BIOINFORMATICS MARKET, BY SERVICES 2013-2020 ($MILLION)
  • TABLE 16: BIOINFORMATICS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 17: BIOINFORMATICS SEQUENCING SERVICES MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 18: BIOINFORMATICS DATABASE &MANAGEMENT SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 19: BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 20: BIOINFORMATICS OTHER SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 21: GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 2013-2020($MILLION)
  • TABLE 22: BIOINFORMATICS GENOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 23: BIOINFORMATICS CHEMOINFORMATICS AND DRUG DESIGN APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 24: BIOINFORMATICS PROTEOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 25: BIOINFORMATICS TRANSCRIPTOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 26: BIOINFORMATICS METABOLOMICS APPLICATION MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 27: BIOINFORMATICS MOLECULAR PHYLOGENETICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 28: BIOINFORMATICS OTHER APPLICATION MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 29: GLOBAL BIOINFORMATICS MARKET BY SECTOR, 2013-2020($MILLION)
  • TABLE 30: MEDICAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 31: ANIMAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 32: AGRICULTURE BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013 - 2020 ($MILLION)
  • TABLE 33: GLOBAL BIOINFORMATICS ACADEMICS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 34: BIOINFORMATICS OTHERS SECTORS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
  • TABLE 35: NORTH AMERICAN BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
  • TABLE 36: EUROPE BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
  • TABLE 37: ASIA PACIFIC BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
  • TABLE 38: ROW BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
  • TABLE 39: ACCELRYS, INC BUSINESS SNAPSHOT
  • TABLE 40: AFFYMETRIX, INC. BUSINESS SNAPSHOT
  • TABLE 41: AGILENT TECHNOLOGIES, INC BUSINESS SNAPSHOT
  • TABLE 42: GENEVA BIOINFORMATICS (GENEBIO) SA BUSINESS SNAPSHOT
  • TABLE 43: NONLINEAR DYNAMICS LTD. BUSINESS SNAPSHOT
  • TABLE 44: QUEST DIAGNOSTICS BUSINESS SNAPSHOT
  • TABLE 45: ILLUMINA, INC. BUSINESS SNAPSHOT
  • TABLE 46: BRUKER DALTONICS, INC. BUSINESS SNAPSHOT
  • TABLE 47: BIOMAX INFORMATICS AG BUSINESS SNAPSHOT
  • TABLE 48: LIFE TECHNOLOGIES BUSINESS SNAPSHOT

LIST OF FIGURES:

  • FIG. 1: VALUE CHAIN ANALYSIS
  • FIG. 2: COMPARATIVE ANALYSIS OF APPLICATION MARKET
  • FIG. 3: PATENT REGISTERED IN THE U.S., EUROPE AND JAPAN
  • FIG. 4: TOP FACTORS IMPACTING IVD MARKET (2013-2020)
  • FIG. 5: TOP WINNING STRATEGIES
  • FIG. 6: TOP INVESTMENT MARKET BY APPLICATIONS
  • FIG. 7: TOP INVESTMENT MARKETS BY SECTOR
  • FIG. 8: PORTER'S FIVE FORCE ANALYSIS
  • FIG. 9: TYPES OF GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
  • FIG. 10: TYPES OF SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
  • FIG. 11: TYPES OF SEQUENCE ANALYSIS PLATFORMS
  • FIG. 12: TYPES OF STRUCTURAL ANALYSIS PLATFORMS
  • FIG. 13: STEPS IN DATABASE & MANAGEMENT
  • FIG. 14: GENOMIC APPLICATIONS BASED ON CLINICAL FIELDS (2012)
  • FIG. 15: GEOGRAPHIC LOCATION OF NEXT GENERATION SEQUENCING (NGS) SUPPLIERS USED IN GENOMICS
  • FIG. 16: CHEMOINFORMATICS WORKFLOW
  • FIG. 17: ROLE OF CHEMOINFORMATICS IN DRUG DISCOVERY
  • FIG. 18: ROLE OF TRANSCRIPTOMICS IN DRUG DISCOVERY
  • FIG. 19: ROLE OF METABOLOMICS IN DIAGNOSTICS
  • FIG. 20: ANALYSIS OF METABOLOMICS DATA
  • FIG. 21: PHYLOGENETIC FOUR STEP ANALYSIS
  • FIG. 22: FARM ANIMAL GENOMICS
  • FIG. 23: CHALLENGES FACED BY BIOINFORMATICS IN ASIA PACIFIC REGION
  • FIG. 24: TOTAL REVENUE BY GEOGRAPHY
  • FIG. 25: SWOT ANALYSIS OF ACCELRYS, INC.
  • FIG. 26: TOTAL REVENUE BY GEOGRAPHY
  • FIG. 27: TOTAL REVENUE BY BUSINESS UNIT
  • FIG. 28: SWOT ANALYSIS OF AFFYMETRIX, INC.
  • FIG. 29: AGILENT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
  • FIG. 30: AGILENT TECHNOLOGIES - REVENUE MIX BY GEOGRAPHY (2013)
  • FIG. 31: KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
  • FIG. 32: KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
  • FIG. 33: SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC
  • FIG. 34: SWOT ANALYSIS OF GENEVA BIOINFORMATICS (GENEBIO) SA
  • FIG. 35: SWOT ANALYSIS OF NONLINEAR DYNAMICS LTD.
  • FIG. 36: PERCENTAGE OF REVENUE GENERATION BY BUSINESS UNITS
  • FIG. 37: SWOT ANALYSIS OF QUEST DIAGNOSTICS
  • FIG. 38: SWOT ANALYSIS OF ILLUMINA, INC.
  • FIG. 39: SWOT ANALYSIS OF BRUKER DALTONICS, INC.
  • FIG. 40: SWOT ANALYSIS OF BIOMAX INFORMATICS AG
  • FIG. 41: FINANCIAL REVENUES BY END MARKETS (2012)
  • FIG. 42: FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
  • FIG. 43: SWOT ANALYSIS OF LIFE TECHNOLOGIES
Back to Top